Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
基本信息
- 批准号:10060282
- 负责人:
- 金额:$ 15.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-10 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AneuploidyCancer BiologyCarcinomaCell modelCellsCoculture TechniquesDevelopmentDevicesEndocrineEnvironmentEpithelialEpithelial CellsEpithelial ovarian cancerEpitheliumEventGrowthHomeostasisHumanLesionMT3 geneMalignant NeoplasmsMalignant neoplasm of ovaryMammalian OviductsMenopauseMolecularMosaicismMusMutationOvarianOvarian FollicleOvarian Granulosa CellOvarian TissuePathway interactionsPopulationPropertyPublishingRegulationResearchResearch Project GrantsResearch Project SummariesRoleTP53 geneTestingTissuesTransgenic OrganismsTumor SuppressionWomanWorkbasecancer riskcancer stem cellcarcinogenesisdesignepithelial stem cellexperimental studygranulosa cellinsightmouse modelmullerian-inhibiting hormonemutant mouse modelparacrineprecursor cellreceptorresponsestem cell populationstem cellsstem-like celltumor
项目摘要
Project Summary
This research project is to study a putative ovarian cancer progenitor and stem cell population, and the impact
of menopause on the potential for the cells to undergo transformation. We have made a surprising discovery
that a mosaic subpopulation of ovarian and fallopian tube epithelial cells is derived from MISR2 (Mullerian
inhibitory substance receptor type 2) lineage. Furthermore, these cells of MISR2-derived subpopulation have
high proliferative potential and develop epithelial tumors in mice that ovarian follicles are depleted. Based on
our recent studies (published and unpublished), we have developed a unique hypothesis that the MISR2-derived
subpopulation of ovarian and fallopian tube epithelial cells are epithelial stem cells and precursors of ovarian
cancer. Additionally, these cells are responsive to suppression by MIS/AMH (Mullerian inhibitory substance/anti-
Mullerian hormone) produced by granulosa cells of ovarian follicles. We plan to test these ideas by studying the
MISR2-containing ovarian and fallopian tube epithelial cells for their growth and stem cell properties, and also
study their response to the MIS factor, in both mouse models and human cells and tissues. Previously, we found
that ovarian follicles and granulosa cells produce a growth inhibitory factor(s) towards ovarian epithelial cells in
culture, and provided evidence that MIS is a strong candidate for the factor. We will seek to identify the factor(s)
produced by granulosa cells using a transwell device for co-culturing of ovarian and fallopian tube epithelial cells
with granulosa cells, and to verify if MIS contributes to part or all of the inhibitory activity. Experiments designed
are also to test the roles of the MIS/MISR2 paracrine/endocrine pathway in maintaining the tissues homeostasis
of the ovarian and fallopian tube environment, and in tumor suppression, as summarized in two main aims. The
first major aim is to characterize the MISR2-positive cells to determine if these cells are progenitor/stem cell like,
and precursors for ovarian cancer. The second major aim is to identify the tumor suppressing factor(s) produced
by follicles/granulosa cells and to study its regulation of ovarian epithelial cells in ovarian tissue homeostasis.
Granulosa cell-derived MIS will be tested as a strong candidate of the follicle-derived factor. The experiments
will use human ovarian cancer tissues, primary and established cells, and transgenic mutant mouse models to
study molecular mechanisms and relevance to human ovarian tissue and cancer. The findings and conclusions
from the study of cell and mouse models will be verified in human normal and cancer tissues. If successful, our
work will solve the long-standing puzzle for the reason why ovarian cancer risk is high in menopausal women.
The research will also gain insight into an ovarian epithelial and cancer stem cell population, and will yield a
substantial new advance in ovarian cancer biology.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XiangXi Mike Xu其他文献
XiangXi Mike Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XiangXi Mike Xu', 18)}}的其他基金
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10524246 - 财政年份:2018
- 资助金额:
$ 15.78万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
9918266 - 财政年份:2018
- 资助金额:
$ 15.78万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10391479 - 财政年份:2018
- 资助金额:
$ 15.78万 - 项目类别:
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention
抑制 Cox-2 预防卵巢癌的机制
- 批准号:
6958678 - 财政年份:2004
- 资助金额:
$ 15.78万 - 项目类别:
相似海外基金
Determining the impact of ancestry on oropharyngeal cancer biology and treatment response.
确定血统对口咽癌生物学和治疗反应的影响。
- 批准号:
10562456 - 财政年份:2023
- 资助金额:
$ 15.78万 - 项目类别:
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
儿科癌症生物学和数据科学交叉领域的放射肿瘤学
- 批准号:
10712290 - 财政年份:2023
- 资助金额:
$ 15.78万 - 项目类别:
Graduate Program in Cancer Biology Training at Emory University
埃默里大学癌症生物学培训研究生课程
- 批准号:
10768333 - 财政年份:2023
- 资助金额:
$ 15.78万 - 项目类别:
Utilizing Multi-omics to Facilitate Cancer Biology Research
利用多组学促进癌症生物学研究
- 批准号:
10733768 - 财政年份:2023
- 资助金额:
$ 15.78万 - 项目类别:
Massive single cell proteomics for cancer biology
用于癌症生物学的大规模单细胞蛋白质组学
- 批准号:
10707321 - 财政年份:2022
- 资助金额:
$ 15.78万 - 项目类别:














{{item.name}}会员




